Related Experiment Video
Updated: Aug 3, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
Factor VII deficiency: A cause of (or risk factor for) bleeding?
1Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, UK.
Factor VII deficiency, the most common rare bleeding disorder, presents challenges in linking genotype to phenotype. Lou and colleagues studied Chinese patients, offering new insights into this genotype-phenotype correlation.
Area of Science:
- Hematology
- Genetics
- Molecular Biology
Background:
- Factor VII deficiency is the most prevalent rare bleeding disorder.
- Establishing a clear correlation between factor VII deficiency and bleeding phenotype remains difficult.
Purpose of the Study:
- To investigate the relationship between genotype and phenotype in a large cohort of Chinese patients with factor VII deficiency.
- To structurally and functionally characterize novel mutations in the F7 gene.
Main Methods:
- Analysis of a large cohort of unrelated factor VII deficient patients.
- Structural and functional characterization of identified F7 mutations.
Main Results:
- Identification and characterization of novel F7 mutations in Chinese patients.
- Provided further perspective on genotype-phenotype correlations in factor VII deficiency.
Conclusions:
- The study enhances understanding of the genetic basis of factor VII deficiency.
- Contributes to improved prediction of bleeding phenotypes based on F7 genotype.
More Related Videos
13:08Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
09:38A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time
Published on: February 14, 2017
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Venous Thrombosis III: Interprofessional Care